Evidence map›Paper›PMID 36032223›Full record

ArticleFrontiers in psychiatry2022

Acceptability and satisfaction with

Margot Morgiève, Daniel Yasri, Catherine Genty, Jonathan Dubois, Marion Leboyer, Guillaume Vaiva, Sofian Berrouiguet, Jérôme Azé, Philippe Courtet

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Margot MorgièveUniversité Paris Cité, CNRS, Inserm, Cermes3, Paris, France.
Daniel YasriUniversité Paris Cité, CNRS, Inserm, Cermes3, Paris, France.
Catherine GentyUniversité Paris Cité, CNRS, Inserm, Cermes3, Paris, France.
Jonathan DuboisUniversité Paris Cité, CNRS, Inserm, Cermes3, Paris, France.
Marion LeboyerFondation Fondamental, Hôpital Albert-Chenevier, Créteil, France.
Guillaume VaivaCHU Lille, Hôpital Fontan, Department of Psychiatry, Lille, France.
Sofian BerrouiguetLaboratoire du Traitement de l'Information Médicale, INSERM UMR1101, CHRU Brest, Brest, France.
Jérôme AzéLIRMM, CNRS, Univ Montpellier, Montpellier, France.
Philippe CourtetUniversité Paris Cité, CNRS, Inserm, Cermes3, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: As mHealth may contribute to suicide prevention, we developed Objective: This study evaluated Methods: Ninety-nine patients at high risk of suicide used Results: Seventy-five patients completed at least one of the proposed EMAs. Completion rates were lower for the daily than weekly EMAs (60 and 82%, respectively). The daily completion rates varied according to the question position in the questionnaire (lower for the last questions, LRT = 604.26, df = 1, Conclusion:

Indexed as

acceptabilityecological momentary assessment (EMA)ecological momentary intervention (EMI)mHealthpreventionsatisfactionsmartphone applicationsuicide

Identifiers

PMID36032223
PMCPMC9403788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.